Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleSupplement

Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer

Andrei H. Iagaru, Erik Mittra, Patrick M. Colletti and Hossein Jadvar
Journal of Nuclear Medicine October 2016, 57 (Supplement 3) 19S-24S; DOI: https://doi.org/10.2967/jnumed.115.170746
Andrei H. Iagaru
1Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik Mittra
1Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick M. Colletti
2Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hossein Jadvar
2Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 57 no. Supplement 3 19S-24S
DOI 
https://doi.org/10.2967/jnumed.115.170746
PubMed 
27694165

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication March 1, 2016
  • Accepted for publication June 1, 2016
  • Published online October 2, 2016.

Copyright & Usage 
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Andrei H. Iagaru1,
  2. Erik Mittra1,
  3. Patrick M. Colletti2 and
  4. Hossein Jadvar2
  1. 1Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California; and
  2. 2Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, California
  1. For correspondence or reprints contact: Hossein Jadvar, Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine, University of Southern California, 2250 Alcazar St., CSC 102, Los Angeles, CA 90033. E-mail: jadvar{at}med.usc.edu.
View Full Text

Statistics from Altmetric.com

Cited By...

  • 26 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Current status of theranostics in prostate cancer
    Irene Virgolini, Clemens Decristoforo, Alexander Haug, Stefano Fanti, Christian Uprimny
    European Journal of Nuclear Medicine and Molecular Imaging 2018 45 3
  • Prospective comparison of 68Ga-PSMA PET/CT, 18F-sodium fluoride PET/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer
    Helle D. Zacho, Julie B. Nielsen, Ali Afshar-Oromieh, Uwe Haberkorn, Nandita deSouza, Katja De Paepe, Katja Dettmann, Niels C. Langkilde, Christian Haarmark, Rune V. Fisker, Dennis T. Arp, Jesper Carl, Jørgen B. Jensen, Lars J. Petersen
    European Journal of Nuclear Medicine and Molecular Imaging 2018 45 11
  • Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment
    Hossein Jadvar
    American Journal of Roentgenology 2017 209 2
  • 203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer
    Mengshi Li, Edwin A. Sagastume, Dongyoul Lee, Daniel McAlister, Anthony J. DeGraffenreid, Keith R. Olewine, Stephen Graves, Roy Copping, Saed Mirzadeh, Brian E. Zimmerman, Roy H. Larsen, Frances L. Johnson, Michael K. Schultz
    Current Medicinal Chemistry 2020 27 41
  • Automated cassette-based production of high specific activity [ 203/212 Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer
    Mengshi Li, Xiuli Zhang, Thomas P. Quinn, Dongyoul Lee, Dijie Liu, Falk Kunkel, Brian E. Zimmerman, Daniel McAlister, Keith Olewein, Yusuf Menda, Saed Mirzadeh, Roy Copping, Frances L. Johnson, Michael K. Schultz
    Applied Radiation and Isotopes 2017 127
  • The Role of Theranostics in Prostate Cancer
    Elisabeth O'Dwyer, Lisa Bodei, Michael J. Morris
    Seminars in Radiation Oncology 2021 31 1
  • Expanding PET-applications in life sciences with positron-emitters beyond fluorine-18
    Heinz H. Coenen, Johannes Ermert
    Nuclear Medicine and Biology 2021 92
  • Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach
    Luca Filippi, Luca Urso, Francesco Bianconi, Barbara Palumbo, Maria Cristina Marzola, Laura Evangelista, Orazio Schillaci
    Expert Review of Molecular Diagnostics 2023 23 3
  • Biomaterials for orthopedic diagnostics and theranostics
    Marian A. Ackun-Farmmer, Clyde T. Overby, Brittany E. Haws, Regine Choe, Danielle S.W. Benoit
    Current Opinion in Biomedical Engineering 2021 19
  • Targeted α-Therapy in Cancer Management: Synopsis of Preclinical and Clinical Studies
    Hossein Jadvar
    Cancer Biotherapy and Radiopharmaceuticals 2020 35 7

Article usage

Article usage: September 2016 to April 2025

AbstractFullPdf
Sep 2016100
Oct 2016108654206
Nov 20164563480
Dec 2016197716
Jan 20172311025
Feb 20171411219
Mar 2017102613
Apr 20171041523
May 2017931936
Jun 2017811730
Jul 2017661620
Aug 2017661319
Sep 2017412025
Oct 2017282227
Nov 2017201219
Dec 2017411411
Jan 2018281115
Feb 2018281015
Mar 2018351031
Apr 2018311124
May 2018322724
Jun 201829313
Jul 201825721
Aug 201819810
Sep 201811313
Oct 201816622
Nov 201824720
Dec 201810421
Jan 201915618
Feb 20192967
Mar 2019161018
Apr 201914819
May 201921611
Jun 20191129
Jul 201917410
Aug 20191308
Sep 201914110
Oct 201921318
Nov 20192018
Dec 20191229
Jan 202014511
Feb 20207712
Mar 2020301112
Apr 202014617
May 202014622
Jun 202016516
Jul 20201158
Aug 2020908
Sep 202021819
Oct 202015613
Nov 20201617
Dec 202013510
Jan 202171117
Feb 2021131832
Mar 202152319
Apr 2021122213
May 2021112712
Jun 202152627
Jul 2021112224
Aug 202172212
Sep 202151717
Oct 202192938
Nov 202182932
Dec 202162714
Jan 20228177
Feb 202251515
Mar 202263534
Apr 202253610
May 2022122740
Jun 202242310
Jul 202223910
Aug 202223513
Sep 202243513
Oct 202253416
Nov 202212339
Dec 20226397
Jan 202364222
Feb 202372816
Mar 202395716
Apr 202353513
May 202353311
Jun 202342614
Jul 202352720
Aug 202342311
Sep 20238319
Oct 202362416
Nov 2023113712
Dec 202334117
Jan 202493816
Feb 2024143913
Mar 2024123026
Apr 20241224625
May 202443412
Jun 202432314
Jul 202453210
Aug 2024132921
Sep 2024113719
Oct 2024114621
Nov 2024146228
Dec 202474612
Jan 202544631
Feb 20251011122
Mar 202566218
Apr 2025159326
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 57 (Supplement 3)
Journal of Nuclear Medicine
Vol. 57, Issue Supplement 3
October 1, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer
Andrei H. Iagaru, Erik Mittra, Patrick M. Colletti, Hossein Jadvar
Journal of Nuclear Medicine Oct 2016, 57 (Supplement 3) 19S-24S; DOI: 10.2967/jnumed.115.170746

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer
Andrei H. Iagaru, Erik Mittra, Patrick M. Colletti, Hossein Jadvar
Journal of Nuclear Medicine Oct 2016, 57 (Supplement 3) 19S-24S; DOI: 10.2967/jnumed.115.170746
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • 18F-NAF PET IN PC
    • 18F-NAF PET/CT VS. 99MTC-MDP BONE SCINTIGRAPHY
    • TARGETED RADIONUCLIDE THERAPY FOR BONE METASTASES
    • 89SRCL2 AND 153SM-ETHYLENEDIAMINETETRAMETHYLENE PHOSPHONATE (153SM-EDTMP)
    • 223RACL2
    • CONCLUSION
    • DISCLOSURE
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Radiotheranostics in Prostate Cancer: Introduction and Overview
  • Google Scholar

More in this TOC Section

  • Recent Advances in Radiotracers Targeting Novel Cancer-Specific Biomarkers in China: A Brief Overview
  • Clinical Implementation of Total-Body PET in China
  • Landscape of Nuclear Medicine in China and Its Progress on Theranostics
Show more Supplement

Similar Articles

Keywords

  • PET/CT
  • PET
  • prostate
  • cancer
  • Bone
  • radium
SNMMI

© 2025 SNMMI

Powered by HighWire